A medication used for heart conditions improves the efficacy of current treatments for melanoma

Credit: Navarrabiomed

Treatment with ranolazine increases the number of antitumor lymphocytes that infiltrate the tumour and favour the action of immunotherapy. NK-type antitumor lymphocytes are stained in green and tumour cells in blue.

« A medication used for heart conditions improves the efficacy of current treatments for melanoma

Expert Pitch

Expert Query

Expert Directory